Dr. Whitesell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Whitehead Institute
9 Cambridge Center
Cambridge, MA 02142Phone+1 617-452-3542Fax+1 617-258-7228- Is this information wrong?
Education & Training
- National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 1989 - 1990
- Boston Children’s Hospital/Boston Medical CenterInternship, Pediatrics, 1984 - 1987
- Johns Hopkins University School of MedicineClass of 1984
Certifications & Licensure
- AZ State Medical License 1994 - 2016
Publications & Presentations
PubMed
- 366 citationsWidespread Macromolecular Interaction Perturbations in Human Genetic DisordersNidhi Sahni, Song Yi, Mikko Taipale, Juan I. Fuxman Bass, Jasmin Coulombe-Huntington
Cell. 2015-04-23 - 197 citationsTransforming Growth Factor β Inhibits the Antigen-Presenting Functions and Antitumor Activity of Dendritic Cell VaccinesJames J. Kobie, Rita S. Wu, Robert A. Kurt, Sunming Lou, Miranda K. Adelman
Cancer Research. 2003-04-15 - 2483 citationsThe immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.Craig L. Bennett, Jacinda R. Christie, Fred Ramsdell, Mary E. Brunkow, Polly J. Ferguson
Nature Genetics. 2001-01-01
Grant Support
- Identifying Species-Specific Anti-Malarial HSP90 Inhibitors Using Genetically ENGNational Institute On Drug Abuse2011
- Generation And Validation Of A Comprehensive Human Disease Mutant ORF ResourceNational Human Genome Research Institute2010
- Identifying Small Molecules To Probe The Role Of Heat Shock Factor 1 In CancerNational Institute On Drug Abuse2009
- Heat Shock Protein Function For Drug DiscoveryNational Cancer Institute2002–2003
- Heat Shock Protein 90 As Modulator Of Tumor Cell SurvivalNational Cancer Institute2001–2002
- Heat Shock Protein Function As A Therapeutic TargetNational Cancer Institute1996–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: